TickerFacts.

A business in context

JNJ research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-02 · 0000200406-26-000179

  2. 4 · Ownership change

    Report date 2026-08-17 · 0000200406-26-000175

  3. 4 · Ownership change

    Report date 2026-08-13 · 0000200406-26-000173

  4. 4 · Ownership change

    Report date 2026-08-05 · 0000200406-26-000171

  5. 4 · Ownership change

    Report date 2026-08-06 · 0000200406-26-000169

  6. 8-K · Current report

    Report date 2026-08-04 · 0000200406-26-000167 · Items 5.02,9.01

  7. 8-K · Current report

    Report date 2026-07-29 · 0000200406-26-000163 · Items 7.01,9.01

  8. 8-K · Current report

    Report date 2026-07-27 · 0000200406-26-000155 · Items 7.01,9.01

  9. 10-Q · Quarterly report

    Report date 2026-06-28 · 0000200406-26-000153

  10. 4 · Ownership change

    Report date 2026-07-20 · 0000200406-26-000148

  11. 8-K · Current report

    Report date 2026-07-15 · 0000200406-26-000146 · Items 2.02,9.01

  12. 4 · Ownership change

    Report date 2026-06-11 · 0000200406-26-000127

  13. 4 · Ownership change

    Report date 2026-06-09 · 0000200406-26-000125

  14. 8-K · Current report

    Report date 2026-04-23 · 0000200406-26-000089 · Items 5.07,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-29 · 0000200406-26-000087

  16. 8-K · Current report

    Report date 2026-04-14 · 0000200406-26-000076 · Items 2.02,8.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-03-11 · 0000200406-26-000063

  18. 10-K · Annual report

    Report date 2025-12-28 · 0000200406-26-000016

  19. 8-K · Current report

    Report date 2026-01-21 · 0000200406-26-000002 · Items 2.02,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-28 · 0000200406-25-000209

  21. 8-K · Current report

    Report date 2025-10-14 · 0000200406-25-000201 · Items 2.02,8.01,9.01

  22. 8-K · Current report

    Report date 2025-09-08 · 0000200406-25-000190 · Items 5.02

  23. 10-Q · Quarterly report

    Report date 2025-06-29 · 0000200406-25-000178

  24. 8-K · Current report

    Report date 2025-07-16 · 0000200406-25-000170 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-10 · 0000200406-25-000152 · Items 5.02

  26. 8-K · Current report

    Report date 2025-04-24 · 0000200406-25-000141 · Items 5.02,5.07,9.01

  27. 10-Q · Quarterly report

    Report date 2025-03-30 · 0000200406-25-000119

  28. 8-K · Current report

    Report date 2025-04-15 · 0000200406-25-000110 · Items 2.02,8.01,9.01

  29. 8-K · Current report

    Report date 2025-03-31 · 0000200406-25-000106 · Items 7.01,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-03-12 · 0000200406-25-000099

  31. 8-K · Current report

    Report date 2025-02-26 · 0001193125-25-036773 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2025-02-20 · 0001193125-25-030851 · Items 8.01,9.01

  33. 10-K · Annual report

    Report date 2024-12-29 · 0000200406-25-000038

  34. 8-K/A · Current report

    Report date 2025-01-22 · 0000200406-25-000007 · Items 9.01

  35. 8-K · Current report

    Report date 2025-01-22 · 0000200406-25-000003 · Items 2.02,9.01

  36. SC 13G/A · Ownership disclosure

    0000904454-24-000574

  37. 10-Q · Quarterly report

    Report date 2024-09-29 · 0000200406-24-000096

  38. SC 13G · Ownership disclosure

    0000904454-24-000538

  39. SC 13G/A · Ownership disclosure

    0000904454-24-000536

  40. 8-K · Current report

    Report date 2024-10-15 · 0000200406-24-000088 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 14 transaction rows14AExercise / conversion: 4 transaction rows4MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

20 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-11
2026-06-12
Wengel Kathryn ES · Sale
Disposed
Common Stock10000.0241.15
2026-06-11
2026-06-12
Wengel Kathryn EM · Exercise / conversion
Acquired
Common Stock10000.0115.67
2026-06-11
2026-06-12
Wengel Kathryn EM · Exercise / conversion
Disposed
Employee Stock Options (Right to Buy)
Derivative security
10000.00.0
2026-06-09
2026-06-11
Woods Eugene A.A · Grant / award
Acquired
Deferred Share Units
Derivative security
161.09232.79
2026-06-09
2026-06-11
Pinto Daniel EA · Grant / award
Acquired
Deferred Share Units
Derivative security
134.24232.79
2026-06-09
2026-06-11
HEWSON MARILLYN AA · Grant / award
Acquired
Deferred Share Units
Derivative security
214.79232.79
2026-05-01
2026-05-04
REED JOHN CF · Tax / exercise payment
Disposed
Common Stock11002.0229.85
2026-05-01
2026-05-04
REED JOHN CM · Exercise / conversion
Acquired
Common Stock25255.00.0
2026-05-01
2026-05-04
REED JOHN CM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
25255.00.0
2026-04-23
2026-04-27
Woods Eugene A.A · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0
2026-04-23
2026-04-27
West NadjaA · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0
2026-04-23
2026-04-27
WEINBERGER MARK AA · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0
2026-04-23
2026-04-27
Pinto Daniel EA · Grant / award
Acquired
Deferred Share Units
Derivative security
1712.00.0
2026-04-23
2026-04-27
MORIKIS JOHN GA · Grant / award
Acquired
Deferred Share Units
Derivative security
1540.00.0
2026-04-23
2026-04-27
McClellan Mark B.A · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0
2026-04-23
2026-04-27
Joly HubertA · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0
2026-04-23
2026-04-27
Johnson Paula AA · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0
2026-04-23
2026-04-27
HEWSON MARILLYN AA · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0
2026-04-23
2026-04-27
Doudna Jennifer AA · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0
2026-04-23
2026-04-27
Beckerle Mary CA · Grant / award
Acquired
Deferred Share Units
Derivative security
975.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000200406JOHNSON & JOHNSON
DePuyNeutrogenaJohnson & Johnson Pharmaceutical Research and DevelopmentJanssen BiotechAlzaCilag AGTibotecJohnson & Johnson Consumer CompaniesJohnson & Johnson Health Care SystemsJohnson & Johnson Innovation - JJDC, Inc.Johnson & Johnson Vision CareLifeScanJohnson & Johnson (United Kingdom)Johnson & Johnson (Ireland)Johnson & Johnson (Sweden)Johnson & Johnson (France)

Showing 16 of 16 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300G0CFPGEF6X2043
GLEIF legal name
Johnson & Johnson
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-07-15T13:22:28Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • J&J · alias · wikidata
  • Johnson and Johnson · alias · wikidata
  • DePuy · subsidiary · wikidata
  • DePuy, A Johnson & Johnson Company · subsidiary · wikidata
  • DePuy Manufacturing · subsidiary · wikidata
  • DePuySynthes, A Johnson & Johnson Company · subsidiary · wikidata
  • DePuy Synthes Companies of Johnson & Johnson · subsidiary · wikidata
  • DePuy Synthes · subsidiary · wikidata
  • Neutrogena · subsidiary · wikidata
  • Neutrogena Corporation · subsidiary · wikidata
  • Johnson & Johnson Pharmaceutical Research and Development · subsidiary · wikidata
  • Janssen Research & Development · subsidiary · wikidata
  • Johnson & Johnson Pharmaceutical Research & Development · subsidiary · wikidata
  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · subsidiary · wikidata
  • Janssen Biotech · subsidiary · wikidata
  • Centocor · subsidiary · wikidata
  • Centocor Biotech · subsidiary · wikidata
  • Centocor Ortho Biotech, Inc. · subsidiary · wikidata
  • Alza · subsidiary · wikidata
  • ALZA Corporation · subsidiary · wikidata
  • Cilag AG · subsidiary · wikidata
  • Cilag · subsidiary · wikidata
  • Tibotec · subsidiary · wikidata
  • Johnson & Johnson Consumer Companies · subsidiary · wikidata
  • Johnson & Johnson, Group of Consumer Companies · subsidiary · wikidata
  • Johnson & Johnson Health Care Systems · subsidiary · wikidata
  • Johnson & Johnson Innovation - JJDC, Inc. · subsidiary · wikidata
  • Johnson & Johnson Innovation · subsidiary · wikidata
  • Johnson & Johnson Vision Care · subsidiary · wikidata
  • LifeScan · subsidiary · wikidata
  • Johnson & Johnson (United Kingdom) · subsidiary · wikidata
  • Johnson & Johnson (Ireland) · subsidiary · wikidata
  • Johnson & Johnson (Sweden) · subsidiary · wikidata
  • Johnson & Johnson (France) · subsidiary · wikidata
  • JOHNSON & JOHNSON ET AL · former SEC name · 1995-10-06 to 1996-01-23
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-29$88.82B$94.55B
2023-12-31$85.16B$93.31B
2023-01-01$79.99B$91.23B
2022-01-02$78.74B$96.97B
2021-01-03$82.58B$106.54B
2019-12-29$82.06B$107.18B
2018-12-30$81.58B$108.48B
2017-12-31$76.45B$104.14B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗